CPA4 and neoplasm: However, after CPA4 was stably silenced in HLCZ01-ETR1R, subcutaneous tumours were implanted in NCG mice, and when the tumour volume was approximately 100 m3, subcutaneous injection of HGS-ETR1 was performed to kill the tumour (Fig. 6u).